WSJ News Exclusive | Farallon Capital to Wage Proxy Battle at Biotech Firm
WSJ News ExclusiveFinanceFarallon has nominated three directors to the board of Exelixis
WSJ News ExclusiveFinanceFarallon has nominated three directors to the board of Exelixis
MarketsStocksHere are seven major companies whose stock moved on the week’s news